A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT05499130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Colitis, Ulcerative

Interventions

DRUG: TEV-48574
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]